| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
myosin heavy chain 6 | 0.581 | 0.615 | 1.6E-32 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 1991 | 1991 | ||||||||
|
myosin heavy chain 7 | 0.516 | 0.692 | 4.2E-16 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 1991 | 1991 | ||||||||
|
integrin subunit alpha 3 | 0.573 | 0.731 | 3.6E-07 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 1991 | 1991 | ||||||||
|
endothelin 1 | 0.380 | 0.846 | 0.46 |
|
phenotype | 0.510 | None | 1.000 | 1 | 0 | 1995 | 2012 | ||||||||
|
very low density lipoprotein receptor | 0.558 | 0.692 | 2.0E-11 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 1996 | 1996 | ||||||||
|
angiotensin II receptor type 1 | 0.423 | 0.846 | 5.3E-04 |
|
phenotype | 0.230 | None | 1.000 | 3 | 0 | 1998 | 2011 | ||||||||
|
annexin A5 | 0.458 | 0.769 | 3.8E-15 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 1998 | 1998 | ||||||||
|
annexin A2 | 0.453 | 0.808 | 9.8E-05 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 1998 | 1998 | ||||||||
|
MET proto-oncogene, receptor tyrosine kinase | 0.380 | 0.846 | 0.97 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 1999 | 1999 | ||||||||
|
fibroblast growth factor 2 | 0.383 | 0.923 | 1.8E-02 |
|
phenotype | 0.500 | None | 1.000 | 1 | 0 | 1999 | 2008 | ||||||||
|
TIMP metallopeptidase inhibitor 4 | 0.559 | 0.769 | 3.8E-04 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 1999 | 1999 | ||||||||
|
ankyrin repeat domain 1 | 0.628 | 0.692 | 2.6E-10 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2000 | 2000 | ||||||||
|
nitric oxide synthase 3 | 0.378 | 0.885 | 6.7E-07 |
|
phenotype | 0.510 | None | 1.000 | 2 | 0 | 2001 | 2018 | ||||||||
|
angiotensinogen | 0.367 | 0.923 | 5.0E-08 |
|
phenotype | 0.500 | None | 1.000 | 2 | 0 | 2001 | 2019 | ||||||||
|
sphingosine-1-phosphate receptor 1 | 0.546 | 0.769 | 0.73 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2001 | 2001 | ||||||||
|
ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 2 | 0.529 | 0.808 | 1.00 |
|
phenotype | 0.500 | None | 1.000 | 1 | 0 | 2001 | 2018 | ||||||||
|
regulator of calcineurin 1 | 0.572 | 0.808 | 1.7E-02 |
|
phenotype | 0.210 | None | 1.000 | 1 | 0 | 2002 | 2005 | ||||||||
|
heart and neural crest derivatives expressed 1 | 0.686 | 0.308 | 0.11 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2002 | 2002 | ||||||||
|
heart and neural crest derivatives expressed 2 | 0.612 | 0.500 | 0.40 |
|
phenotype | 0.500 | None | 1.000 | 1 | 0 | 2002 | 2018 | ||||||||
|
natriuretic peptide A | 0.505 | 0.769 | 5.5E-04 |
|
phenotype | 0.500 | None | 1.000 | 1 | 0 | 2002 | 2013 | ||||||||
|
platelet derived growth factor receptor beta | 0.416 | 0.846 | 0.90 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2002 | 2002 | ||||||||
|
glycogen phosphorylase, muscle associated | 0.650 | 0.577 | 2.0E-13 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2003 | 2003 | ||||||||
|
S100 calcium binding protein A1 | 0.421 | 0.846 | 6.0E-03 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2003 | 2003 | ||||||||
|
protein kinase C beta | 0.453 | 0.885 | 1.00 |
|
phenotype | 0.500 | None | 1.000 | 1 | 0 | 2003 | 2007 | ||||||||
|
NME/NM23 nucleoside diphosphate kinase 1 | 0.443 | 0.808 | 3.2E-03 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2003 | 2003 |